Prittle Prattle Pr

Category: Health

  • HRV Global Life Sciences Leads First-Ever Export of Indian Anti-Diabetic Drugs to Argentina’s Mendoza

    In a historic cross-continental healthcare shift, HRV’s Metformin shipment lands in Mendoza under $150K public health initiative, marking India’s growing role in global pharma.

    In a defining moment for international pharmaceutical collaboration, HRV Global Life Sciences has achieved a landmark milestone by delivering the first-ever shipment of Indian-manufactured Metformin (1000mg) to Mendoza, Argentina. This milestone marks a new chapter in strengthening the health diplomacy between India and Argentina, offering affordable diabetes management solutions through Mendoza’s public health system.
    This pioneering effort was made possible under the leadership of Alfredo Cornejo, Governor of Mendoza, and Dinesh Bhatia, Ambassador of India to Argentina. The initiative gained momentum following strategic deregulation led by President Javier Milei, Minister of Health Mario Lugones and Minister of Deregulation Federico Sturzenegger.
    Backed by a $150,000 investment from the Mendoza provincial government, this procurement achieved an estimated 45–50% cost saving compared to conventional drug imports, emphasizing India’s increasing role in global pharmaceutical supply chains.

    “This milestone delivery is not just about pharmaceutical logistics. It is about access, equity, and vision. We are proud to collaborate with Argentina to make quality medication affordable and widely accessible,” shared Hari Kiran Chereddi, Managing Director of HRV Global Life Sciences.
    The consignment included USFDA-compliant Metformin manufactured through HRV’s Contract Development and Manufacturing Organization (CDMO) partner. This also serves as a successful validation of the company’s pioneering virtual pharma model – a first of its kind in India covering both Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs).

    HRV Global Life Sciences, founded in 2015 and headquartered in Hyderabad, operates across USA, Switzerland, Dubai, Lithuania, and Turkey. It collaborates with over 55 Indian drug substance manufacturers and serves 100+ corporations across Europe, Latin America, and the Middle East.
    This strategic collaboration not only highlights India’s leadership in cost-efficient, high-quality pharmaceuticals but also paves the way for future exports across Argentina’s other provinces and into additional therapeutic areas such as oncology and cardiology.

    “Metformin is more than a medicine. It’s a lifeline for millions,” said Rodolfo Montero, Mendoza’s Minister of Health. “Our partnership with HRV Global Life Sciences proves that visionary policy combined with international cooperation can transform public healthcare.”
    This initiative reflects a broader wave of global healthcare diplomacy where virtual pharmaceutical models from India are now reaching patients across continents, with sustainability and scalability at their core.
    Published by Prittle Prattle News , featuring you virtuously. Editor: Smruti Bhalerao | Channel: @prittleprattlenews
    At Prittle Prattle News, featuring you virtuously, we celebrate the commitment and innovation. Led by Editor-in-Chief Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.

  • India’s Most Trusted Dental ChainIndia’s Most Trusted Dental Chain, Clove Dental, Celebrates 14 Years with 600 Clinics and 3 Million Smiles

    With state-of-the-art sterilization, AI-enabled care, and patient-first pricing, Clove Dental sets the benchmark in modern oral healthcare.

     Clove Dental, India’s largest dental network, marked a significant milestone by launching its 600th clinic in Gurugram on its 14th anniversary. Since its inception in 2011, Clove Dental has evolved from a single-chair clinic into a nationwide network spanning over 26 cities, having treated more than 3 million patients.
    Founded by Amarinder Singh and operated under Global Dental Services, Clove Dental has disrupted India’s fragmented dental market by offering accessible, technology-driven, and ethically transparent oral care. With a deep focus on preventive dentistry and patient trust, the organization has successfully built a reputation in both metro and Tier-II cities.
    The 600th clinic’s opening was not merely symbolic, it reflected Clove’s unwavering commitment to making safe, high-quality dental care available to every Indian. The new facility in Gurugram is equipped with digital X-ray units, ergonomic dental chairs, and AI-backed sterilization processes, ensuring both clinical precision and patient confidence.

    Louis Shakinovsky, Group Chairman of Global Dental Services, remarked, “Credibility is doing what you say. Our Clove team has done this convincingly. When we set out to revolutionize dentistry in India, our vision was bold but rooted in service. Today, reaching 600 clinics is not just a number, it’s proof of trust delivered, city after city.”
    Amarinder Singh, Founder & CEO, noted, “At Clove Dental, trust is the cornerstone. From AI-led sterilization and computer-controlled pricing to full compliance with Dental Council of India protocols, we ensure each patient is informed and confident. Our focus is not just on volume, but on ethical, transparent dentistry.”

    Leading clinical innovation, Lt Gen Dr. Vimal Arora, Chief Clinical Officer at Clove, emphasized that all clinics are equipped with the most current technology and staffed with specialists trained in the latest techniques. “Every Clove clinic is built to deliver a safe, aseptic, and comfortable experience. Skill enhancement and outcome monitoring is part of our DNA,” he added.
    Clove Dental offers a full range of dental services under one roof: root canal treatment, dental fillings, wisdom tooth removal, paediatric dentistry, clear aligners, braces, dental implants, laser dentistry, crowns, bridges, dentures, mouth ulcer treatment, gum disease management, and preventive care. It has placed over 55,000 implants and handled more than 35,000 orthodontic cases.

    While the dental care industry in India remains largely unregulated and fragmented, Clove Dental has led the shift towards organized dentistry. Compared to competitors such as Sabka Dentist, MyDentalPlan, and Apollo White Dental, Clove stands out for its clinical protocols, tech integration, and ethical pricing.
    Clove Dental clinics follow a sterilization process that includes AI-enabled computer vision tracking, multi-stage instrument cleansing, and digital record-keeping for compliance. Its sterilization protocol has become an industry benchmark and is being studied for adoption in other emerging healthcare segments.
    The rise of dental tech in India has been gradual, but Clove Dental is pushing boundaries by implementing standards seen in countries like Japan, Germany, and Singapore. Its commitment to digital integration aligns with India’s broader Digital Health Mission.
    According to WHO, oral health is linked to chronic conditions like diabetes and cardiovascular disease. Clove Dental addresses this with a preventive-first model, integrating oral screening with general health awareness.

    As Clove Dental celebrates this landmark, its mission is only getting bolder: to create India’s most reliable, accessible, and technologically advanced oral care ecosystem. It plans to deepen its reach into Tier-II and Tier-III cities, empowering families who previously lacked access to affordable and ethical dental services.
    Prittle Prattle News, featuring you virtuously, brings you this story as part of our continued spotlight on Indian healthcare innovation and responsible entrepreneurship.
    To learn more about Clove Dental’s services and locations, visit https://clovedental.in.
    At Prittle Prattle News, featuring you virtuously, we celebrate the commitment and innovation. Led by Editor-in-Chief Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.

  • Transforming to Precision Robotics: Apollo, Fortis & Nanavati Max Lead a New Era in Women’s Healthcare

    With robotic-assisted surgery redefining women’s health, leading experts Dr. Rooma Sinha, Dr. Swapna Misra & Dr. Uddhavraj Dudhedia urge early adoption to tackle gynaecological disorders

    Gynaecological disorders are on the rise in India, with conditions such as fibroids, ovarian cysts, endometriosis, and gynaecological cancers becoming increasingly prevalent. Healthcare experts stress the need for advanced surgical solutions, such as robotic-assisted surgery, to ensure better patient outcomes with reduced recovery times and minimal discomfort.

    The Silent Crisis: The Growing Burden of Gynaecological Disorders in India
    Women’s health has long been an overlooked area in mainstream healthcare discussions, but the alarming rise in gynaecological disorders has made it an urgent priority. Conditions such as fibroids, endometriosis, benign tumors, and ovarian and endometrial cancers are increasingly being diagnosed, affecting women’s quality of life. However, due to social stigma and fear of traditional surgical complications, many hesitate to seek timely intervention.

    According to Dr. Rooma Sinha, Founder & President of Gynaecological Robotic Surgeons and Chief of Gynaecology at Apollo Hospital Jubilee Hills, Hyderabad, precision medicine is the key to changing this reality.

    “Women already suffer from late menopause, irregular cycles, high-dose hormone therapies for infertility, metabolic disorders, and now ovarian and endometrial tumors. If they also have to endure the trauma of traditional surgery, it is unfair. But with robotic-assisted surgery, we can ensure minimal scarring, reduced pain, and faster recovery. With the da Vinci surgical system, patients are often discharged within 24 hours, and some even within 8-10 hours post-surgery.”

    Robotic-Assisted Surgery: A Paradigm Shift in Women’s Healthcare
    Minimally invasive surgery, powered by robotics and artificial intelligence, has drastically transformed surgical outcomes. With precision, enhanced visualization, and improved dexterity, robotic-assisted techniques have revolutionized oncology, particularly in women’s cancers.

    Dr. Swapna Misra, a certified International Robotic Gynaecological Surgeon at Fortis Hospital Mohali, highlights the urgent need for awareness:
    “The rising burden of endometrial and ovarian cancer is a pressing health crisis. The modern lifestyle, marked by chronic stress, obesity, and hormonal imbalances, is now affecting younger women, with diagnoses occurring as early as 25-35 years. Early screenings, combined with advanced robotic surgery, can significantly improve survival rates.”

    Overcoming Fear & Misinformation: Need for Better Awareness
    Despite medical advancements, lack of awareness and misconceptions about new technologies remain major barriers to care.

    Dr. Uddhavraj Dudhedia, Gynaecological Robotic Oncosurgeon at Nanavati Max Super Speciality Hospital, Mumbai, stresses the need to bridge this gap:
    “Many women hesitate to seek treatment due to fear of traditional surgery disrupting their lives. The absence of awareness about robotic-assisted surgery leads to delayed decision-making and prolonged suffering. From a comparative standpoint, I have observed that minimally invasive procedures using advanced technologies like da Vinci robotics reduce pain by 30-40% compared to conventional surgery. This not only enhances patient comfort but also improves overall recovery rates.”

    Beyond Oncology: The Future of Women’s Health & Robotics
    The application of robotics in gynaecology is not limited to oncology. It is increasingly being used in cases such as hysterectomies, myomectomies (removal of fibroids), and complex pelvic reconstructive surgeries.

    Dr. Devika Gunasheela, Founder of Tattvagene & Gunasheela Hospital, emphasizes how genetic testing and AI-driven reproductive healthcare are transforming fertility treatments:
    “Infertility is not just a medical condition but an emotional and societal challenge. Many women face stigma when they struggle with conception. Genetic screening and AI-driven fertility treatments are transforming reproductive healthcare, improving pregnancy outcomes.”

    Similarly, Dr. Sulochana Gunasheela, who pioneered IVF treatments in India, notes:
    “Decades ago, when we introduced IVF, people were skeptical. Today, we integrate genetic testing and AI-based embryo selection to improve success rates and reduce emotional stress for aspiring mothers.”

    The Intersection of Women’s Health & Workplace Policies
    Beyond clinical advancements, women’s health must be integrated into corporate policies to ensure well-being across different life stages. Dr. Kavita Bhardwaj, Head of Exploration at Hindustan Zinc, believes:

    “Women’s healthcare goes beyond maternal care. Workplace policies must address menstrual health, fertility treatments, and menopause to ensure that women do not have to choose between their careers and their health.”

    Healthcare Accessibility for Working Women & Entrepreneurs
    Maternity care and preventive screenings remain critical gaps for women entrepreneurs and working professionals. Madhura DasGupta Sinha, Founder & CEO of Aspire for Her, emphasizes:

    “80% of women entrepreneurs struggle with healthcare access while managing businesses. We must build an ecosystem that supports working women with better insurance, maternity benefits, and preventive screenings.”

    Similarly, Saibal Biswas, SVP at MediBuddy, highlights how digital healthcare can fill these gaps: “MediBuddy’s #HerHealthBuddy campaign tackles period stigma, reproductive health myths, and the gender gap in medical research. Women’s health must be prioritized year-round, not just on Women’s Day.”

    Final Take: Prioritizing Women’s Healthcare Beyond a Single Day
    The advancement of robotic-assisted surgery, the integration of AI in fertility treatments, and the push for corporate healthcare policies reflect a new era for women’s health. The conversation must extend beyond Women’s Day to become an integral part of policy-making, workplace benefits, and medical research.
    With Apollo, Fortis, and Nanavati Max leading the charge, it’s time to accelerate early detection, advanced surgical options, and equal access to healthcare for women across all walks of life.
    At Prittle Prattle News, featuring you virtuously, we celebrate the commitment and innovation. Led by Editor-in-Chief Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.

  • Pharma’s Next Big Shift: BCG & IPSO Chart India’s CRDMO Path to a $25 Billion Global Opportunity

    A new BCG-IPSO report highlights how India’s CRDMO firms are scaling talent, infrastructure, and innovation to capture a larger share of the $145 billion global pharma outsourcing market.

    India’s Contract Research, Development, and Manufacturing Organization (CRDMO) sector is undergoing a transformation, with projections placing it at $25 billion by 2035. A new report, “Unleashing the Tiger: Indian CRDMO Sector 2025”, published by Boston Consulting Group (BCG) and Innovative Pharmaceutical Services Organization (IPSO), outlines India’s growing influence in global pharmaceutical innovation.
    The report highlights how eleven leading CRDMO firms have joined forces under IPSO to move beyond traditional outsourcing. The goal is to position India as a leader in biologics, RNA therapeutics, and advanced drug development, with strong support from government-backed initiatives and global supply chain shifts.

    India’s CRDMO market is expanding at a 15% CAGR, surpassing global industry growth. As pharmaceutical companies diversify manufacturing beyond China, India’s expertise in small molecules, biologics, and Antibody Drug Conjugates (ADCs) presents a major advantage. The report states that global supply chain realignments are unlocking a $10 billion opportunity for Indian CRDMOs.
    Peter Bains, CEO Designate of Syngene International Ltd., emphasized that India is no longer just a low-cost outsourcing hub but is advancing towards high-value pharmaceutical innovation. He stated that IPSO’s efforts would accelerate India’s leadership in cutting-edge drug research and biomanufacturing.

    IPSO’s Role in India’s CRDMO Expansion
    IPSO is bringing together leading Indian CRDMOs, including Syngene International, Aragen Life Sciences, Piramal Pharma Solutions, Sai Life Sciences, Neuland Laboratories, Aurigene, and Jubilant Biosys. This coalition aims to enhance India’s drug discovery capabilities, strengthen regulatory frameworks, and promote international partnerships.
    Manni Kantipudi, CEO of Aragen Life Sciences, noted that IPSO represents a strategic shift for the Indian CRDMO sector. He highlighted that India must move beyond small-molecule manufacturing and focus on biologics, ADCs, and gene therapies to capture a larger share of the $145 billion global CRDMO market.
    Vikash Agarwalla, Managing Director at BCG, emphasized that while India’s cost advantage, talent pool, and policy support are strong, the industry must address critical funding, regulatory, and sustainability challenges to fully capitalize on the $25 billion potential.

    Key Challenges on the Road to $25 Billion
    Despite strong growth, India’s CRDMO sector must overcome several challenges to achieve its full potential. The BCG-IPSO report outlines five key areas that require immediate attention:
    India needs to scale its talent pool by 6-7x by 2035, particularly in biologics, ADCs, and gene therapy. The regulatory approval process must be streamlined to enable faster clinical trials and drug approvals. IPSO is advocating for a more competitive regulatory framework to help Indian firms compete with United States, European Union, and Japan in securing global partnerships.
    India currently imports a significant portion of its Active Pharmaceutical Ingredients (APIs), making supply chain resilience a key focus. Strengthening the domestic Tier 1 supplier base is crucial to reducing dependence on imports. Capital investment in CRDMOs needs to increase by 4-5x to build world-class R&D infrastructure. IPSO is working with policymakers to encourage financial incentives for research, manufacturing, and digital transformation.
    With global pharma firms adopting Environmental, Social, and Governance (ESG) compliance standards, Indian CRDMOs need to align with sustainable manufacturing practices to remain competitive in international markets.

    Global Pharma’s Shift: India’s Growing Influence in CRDMO
    The global pharmaceutical industry is evolving, and India is emerging as a preferred destination for contract research and drug development.
    Pharmaceutical giants are actively diversifying their supply chains, with a shift away from China to India and Southeast Asia. Regulatory policies such as the US Inflation Reduction Act (IRA) are encouraging offshoring to cost-effective hubs like India. Additionally, the Indian government’s ₹25,000 crore R&D investment is fueling the country’s rise as a center for biologics, cell and gene therapy, and next-generation drug manufacturing.
    Smruthi Suryaprakash, Partner at BCG, explained that IPSO is helping Indian CRDMOs move beyond outsourcing to full-scale drug discovery. She noted that India is now competing with the world’s top pharmaceutical research hubs and has the potential to become a leader in high-value drug manufacturing.

    India’s CRDMO Future: A $25 Billion Global Opportunity
    With IPSO driving collaboration, India’s CRDMO sector is poised to play a central role in global pharmaceutical research and manufacturing. The next decade will determine whether India can fully capitalize on its scientific expertise, infrastructure, and policy advantages to secure a larger share of the global pharma market.

    At Prittle Prattle News, featuring you virtuously, we celebrate the commitment and innovation. Led by Editor-in-Chief Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.

  • From Ultramarathons to Everyday Wellness: Milind Soman & Garmin Are Transforming Fitness in India

    Garmin’s Beat Yesterday philosophy aligns with Milind Soman’s fitness journey, making this collaboration a perfect fit for India’s growing wellness movement.

    Global fitness technology leader Garmin has taken a bold step to strengthen its presence in India by appointing Milind Soman as its new brand ambassador. With India emerging as one of the most dynamic fitness markets, this partnership is set to revolutionize how individuals approach health, endurance, and wellness.
    Milind Soman, known for his ultramarathons, Ironman races, and dedication to fitness, will advocate for Garmin’s cutting-edge wearable technology, inspiring people to integrate smart tracking and performance insights into their fitness journeys. His achievements include completing the Ironman Triathlon, the Ultraman Florida Challenge, and setting a Limca Book of Records milestone by running 1,500 kilometers across India.

    A Strategic Move to Elevate Fitness Tracking in India
    Garmin has identified India as one of its fastest-growing markets, with an increasing demand for precision-based fitness tracking. With smartwatches catering to activities including running, cycling, swimming, yoga, hiking, golf, and diving, Garmin is making intelligent fitness tracking an essential tool for all fitness levels.
    Garmin smartwatches are designed to monitor heart rate, VO2 max, sleep patterns, stress levels, and hydration, helping individuals set personalized goals and optimize recovery. By bringing Milind Soman on board, Garmin aims to connect with professional athletes, fitness enthusiasts, and beginners, reinforcing its commitment to making data-driven fitness accessible to everyone.
    Expressing his enthusiasm, Milind Soman shared that he has been using Garmin products for years and has always been impressed with their accuracy and reliability. He believes Garmin’s technology will encourage more people to embrace fitness, regardless of their starting point.

    Garmin’s Vision: Blending Innovation with Everyday Fitness
    Announcing the partnership, Deepak Raina, General Manager – AMIT GPS & Navigation, emphasized that Garmin’s wearable technology is designed to go beyond fitness tracking. The company’s approach is centered around helping individuals unlock their potential through real-time insights, training plans, and scientific performance analysis.
    Garmin smartwatches are widely trusted in triathlon training, marathon running, motorsports, horse riding, and archery. By leveraging Milind Soman’s influence, Garmin is set to introduce a new wave of smart fitness adoption in India, making performance-driven wellness more accessible, engaging, and impactful.
    For more details on Garmin’s latest range of smartwatches and fitness wearables, visit Garmin.

    About Garmin
    Founded in 1989, Garmin is a world leader in GPS technology and wearable fitness devices, specializing in sports, aviation, automotive, and marine navigation. With a strong focus on innovation and user-driven performance tracking, Garmin has built a global reputation for cutting-edge smartwatch technology that supports individuals in optimizing their health and fitness.
    Milind Soman is an ultramarathon runner, fitness promoter, and entrepreneur, widely recognized as India’s most influential fitness icon. Known for his extraordinary endurance feats, including the Ironman Triathlon and the Ultraman Florida Challenge, Milind has dedicated his career to inspiring people to lead healthier, more active lives.
    At Prittle Prattle News, featuring you virtuously, we celebrate the commitment and innovation. Led by Editor-in-Chief Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.

  • Cervical Cancer is 100% Preventable Yet Millions Ignore Screening. Here’s Why That Must Change

    Early diagnosis and HPV vaccines could eliminate cervical cancer worldwide. Dr. Avir Sarkar, Assistant Professor at NIIMS Medical College & Hospital, explains why awareness and screening are the key to survival.

    Cervical cancer is one of the most preventable yet deadly cancers affecting women worldwide. Despite medical advancements, it remains the fourth most common cancer among women, with over 570,000 new cases reported globally each year. In India alone, more than 123,000 women are diagnosed annually, making it the second most common cancer among Indian women after breast cancer, according to ICMR.
    Dr. Avir Sarkar, Assistant Professor at NIIMS Medical College & Hospital, emphasizes that early screening, HPV vaccination, and lifestyle changes can drastically reduce the risk of cervical cancer. However, a lack of awareness and regular testing continues to be a major hurdle in eradicating this preventable disease.
    According to Dr. Avir Sarkar, HPV vaccines and regular screenings are life-saving tools. If all women undergo regular Pap smears and receive the HPV vaccine, cervical cancer cases could be virtually eliminated.

    Cervical cancer develops when cells in the cervix grow uncontrollably, often due to a persistent infection by human papillomavirus (HPV), a virus transmitted primarily through sexual contact. While many HPV infections resolve naturally, certain high-risk strains, especially HPV-16 and HPV-18, cause nearly 70 percent of all cervical cancer cases. Several factors can increase the risk of developing cervical cancer, including smoking, a weakened immune system, long-term use of contraceptives, multiple sexual partners, and a history of other sexually transmitted infections.
    The HPV vaccine is a powerful preventive measure, offering protection against the most common cancer-causing HPV strains. Studies from WHO confirm that HPV vaccination reduces the risk of cervical cancer by nearly 90 percent when administered before exposure to the virus. The vaccine is recommended for boys and girls around the ages of 11 or 12, though catch-up vaccination is available up to age 26. Despite its effectiveness, vaccine coverage remains low in India due to a lack of awareness and accessibility challenges. Expanding HPV vaccination programs could drastically cut future cervical cancer cases.

    Regular Pap smears and HPV tests can detect cervical abnormalities long before they develop into cancer. Early detection allows for timely treatment, increasing the chances of a full recovery. Medical experts recommend that women begin Pap tests at age 21 and repeat them every three years. From age 30, women may opt for co-testing, combining Pap and HPV tests every five years if initial results are normal.
    According to Dr. Avir Sarkar, screening is just as critical as vaccination. A single Pap test can detect abnormal cells years before cancer develops, giving women the best chance at early intervention. Despite the availability of screening programs, many women in India never undergo a single Pap smear. Increasing awareness about routine screening could significantly reduce cervical cancer-related deaths.
    Beyond vaccination and screening, certain lifestyle changes can help lower the risk of cervical cancer. A strong immune system plays a crucial role in clearing HPV infections before they cause long-term harm. Medical professionals recommend quitting smoking, practicing safe sex, maintaining a balanced diet, and engaging in regular physical activity. Encouraging these habits alongside widespread vaccination and screening programs can significantly reduce the burden of cervical cancer in India.

    Cervical cancer is preventable through early diagnosis, HPV vaccination, and regular screening. The medical community, along with government health programs, must ensure that every woman has access to these life-saving services. Public health campaigns should focus on dispelling myths surrounding the HPV vaccine, improving screening accessibility, and integrating cervical cancer prevention into routine healthcare visits.
    According to Dr. Avir Sarkar, we need collective action from healthcare professionals, policymakers, and communities to make HPV vaccination and regular screening a priority. Cervical cancer survival rates improve dramatically with early intervention. By increasing awareness and preventive measures, India can move closer to eliminating this disease as a major public health concern.
    At Prittle Prattle News, we bring you deeply researched, high-impact storytelling that goes beyond the ordinary. From fashion’s most iconic moments to exclusive interviews with India’s greatest designers, we deliver stories that shape the industry. Follow us on LinkedIn, Instagram, and YouTube for exclusive updates.

  • Transforming Rishikesh’s Wellness Landscape: Chalet Hotels’ New Chapter With The Westin Resort & Spa

    With a Rs. 5.3 billion investment, Chalet Hotels strengthens its presence in Rishikesh, the heart of India’s wellness and spiritual tourism.

    Mumbai, February 10th, 2025: Chalet Hotels Limited (CHL), a part of K Raheja Corp, has announced its acquisition of The Westin Resort & Spa, Himalayas, a luxurious 141-room property nestled in the serene foothills of the Himalayas. This move marks a strategic step in CHL’s expansion into India’s high-growth wellness, leisure, and spiritual tourism markets, positioning the company at the forefront of transformative hospitality experiences.
    The acquisition involves the purchase of a 100% stake in Mahananda Spa and Resorts Private Limited, the owning company of The Westin Resort & Spa, Himalayas, from Mankind Pharma Limited. With an enterprise value of Rs. 5.3 billion, CHL is now in the process of finalizing the definitive agreement. This acquisition complements CHL’s mission to redefine premium hospitality while unlocking new avenues of growth in a booming tourism segment.
    Opened in January 2023, The Westin Resort & Spa, Himalayas, has already established itself as a destination for luxury, wellness, and tranquility, achieving an ADR (Average Daily Rate) of over Rs. 26,000 and an occupancy rate of 45% as of YTD December 2024. These impressive figures highlight the resort’s significant contribution to the region’s growing reputation as a wellness hub.

    A Jewel in the Heart of Rishikesh
    Strategically located near the spiritual hub of Rishikesh, often referred to as the “Yoga Capital of the World,” The Westin Resort & Spa is surrounded by the breathtaking beauty of the Himalayan foothills. The property is easily accessible, being just 45 minutes from Jolly Grant Airport in Dehradun, making it an ideal getaway for both domestic and international travelers.
    The resort offers 141 tastefully designed rooms, providing panoramic views of the Himalayas and the lush Ganges River valley. With over 10,000 sq. ft. of event space, the property caters to weddings, corporate retreats, and social gatherings. Its Grand Ballroom is the largest in the region, while the expansive outdoor lawns create a picture-perfect backdrop for weddings and cultural events.
    A key highlight is the Heavenly® Spa by Westin, which blends traditional Himalayan therapies with modern wellness practices, making it a sought-after destination for rejuvenation. Additionally, the WestinWorkout® Fitness Studio caters to guests seeking an active lifestyle amidst serene surroundings. The property also boasts world-class dining options that combine local flavors with international cuisines, enhancing the overall guest experience.

    Leadership Vision and Strategy
    Speaking about the acquisition, Dr. Sanjay Sethi, Managing Director and CEO of Chalet Hotels Limited, stated, This acquisition is a significant milestone in our journey to expand Chalet Hotels’ footprint in India’s high-growth luxury and leisure segment. The Westin Resort & Spa, Himalayas, is more than just a property—it’s a wellness destination that perfectly aligns with our vision of creating transformative guest experiences. With this addition, we aim to cater to evolving traveler preferences, offering them the best of both worlds: luxury and tranquility.
    Dr. Sethi added that Rishikesh’s growing prominence as a hub for spirituality, yoga, and wellness makes it an ideal destination for Chalet Hotels’ next chapter. The acquisition reinforces the company’s commitment to delivering world-class hospitality while supporting the local economy through sustainable tourism.

    Chalet Hotels’ Legacy of Excellence
    Chalet Hotels Limited is an industry leader in India’s hospitality sector, with a diversified portfolio of 10 operating hotels and resorts featuring over 3,052 keys under globally recognized brands such as JW Marriott, The Westin, and Novotel. The company has another ~1,000 rooms under development, further strengthening its position as a pioneer in high-end hospitality.
    As part of its commercial real estate ventures, Chalet Hotels is augmenting its portfolio from 2.4 million sq. ft. to 3.3 million sq. ft., creating a robust pipeline of growth. The company’s commitment to sustainability is reflected in its Dow Jones Sustainability Index (DJSI) score of 57 and its participation in global climate initiatives like RE100, EP100, and EV100.

    The Future of Rishikesh Tourism
    This acquisition marks a turning point for Rishikesh, placing it firmly on the map as a global destination for luxury and wellness tourism. With Chalet Hotels’ operational expertise and The Westin Resort & Spa’s existing reputation for excellence, the region is poised to attract a new wave of travelers seeking immersive wellness experiences.
    As India embraces the Atmanirbhar Bharat initiative and focuses on developing its tourism and hospitality infrastructure, Chalet Hotels’ strategic investments are contributing to the nation’s economic and cultural growth. By blending luxury with tradition, The Westin Resort & Spa is set to redefine hospitality in one of India’s most iconic locations.
    Chalet Hotels Limited, part of the K Raheja Corp group, is an owner, developer, and operator of premium hotels and resorts in India. With a legacy of delivering world-class hospitality experiences, Chalet Hotels is recognized for its commitment to innovation, sustainability, and excellence in service.
    Final Thoughts
    With the addition of The Westin Resort & Spa, Himalayas, Chalet Hotels has embarked on a new journey of luxury, wellness, and transformative hospitality. This acquisition not only enhances Chalet Hotels’ portfolio but also sets the stage for the company’s growth in India’s burgeoning leisure and wellness tourism sector. As The Westin Resort & Spa welcomes travelers to Rishikesh, it stands as a beacon of serenity, elegance, and modern luxury, reflecting the essence of what Chalet Hotels strives to deliver.
    At Prittle Prattle News, featuring you virtuously, we celebrate the commitment and innovation. Led by Editor-in-Chief Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.

  • IKS Health’s AI-Led Growth Surge: Record 16% Revenue Jump and 28% PAT Growth in Q3 FY25

    With AI-driven automation and strategic expansion, IKS Health strengthens its position as a leader in care enablement and healthcare transformation.

    With AI-driven automation and strategic expansion, IKS Health strengthens its position as a leader in care enablement and healthcare transformation.

    India, February 5, 2025: IKS Health (NSE: IKS) has delivered a stellar Q3 FY25 performance, driven by its aggressive push into AI-powered automation and care enablement solutions. The company reported a 16% year-on-year (YoY) increase in revenue, alongside a 28% YoY jump in profit after tax (PAT), highlighting its ability to optimize healthcare workflows, reduce operational inefficiencies, and enhance patient care.
    The healthcare automation market is expected to surpass $90 billion globally by 2027, and IKS Health is leading the charge in transforming clinical documentation, patient engagement, and revenue cycle management. With EBITDA margins crossing 30% for the first time, the company is now focused on scaling AI-driven efficiencies across physician groups, hospitals, and specialty care enterprises.

    Sachin K. Gupta, Founder & CEO, IKS Health, emphasized the company’s commitment to continuous AI innovation:
    “Our rapid growth is a testament to the power of AI-driven healthcare transformation. We are not just optimizing workflows, we are fundamentally reshaping how healthcare enterprises function. Our Care Enablement Platform integrates AI, automation, and human expertise to deliver tangible financial and clinical outcomes.”
    Expanding on financial performance, Nithya Balasubramanian, CFO, IKS Health, noted:
    “With a sharp focus on operational efficiencies, we have significantly improved EBITDA margins while reducing finance costs. Our adjusted PAT has surged by 31%, reflecting our disciplined execution and commitment to long-term sustainability.

    AI-Powered Innovation and Strategic Expansion
    IKS Health’s aggressive AI adoption is setting a new benchmark in healthcare automation. The recent launch of Scribble AI, an advanced natural language processing (NLP)-driven clinical documentation tool, is already delivering results for healthcare providers. By automating audio-to-text medical notes, reducing physician burnout, and ensuring HIPAA-compliant data security, the platform is helping clinicians focus on care delivery instead of paperwork.
    Key AI-driven innovations include:

    • Automated real-time clinical documentation, cutting down time spent on administrative tasks.
    • AI-powered revenue cycle management, enhancing claims accuracy and reimbursement rates.
    • Patient engagement solutions, improving access and satisfaction scores for healthcare enterprises.

    High-Profile Client Wins Strengthen Market Leadership
    IKS Health’s growing list of marquee clients underscores its dominance in AI-enabled care enablement solutions. Palomar Health, Radiology Partners, and Western Washington Medical Group are among the latest physician enterprises leveraging IKS Health’s automation-first approach to enhance financial sustainability and operational efficiency.
    By combining data analytics, AI-driven automation, and medical expertise, IKS Health is transforming how healthcare enterprises scale operations while maintaining high-quality patient care.
    Industry Recognition and Market Momentum
    IKS Health continues to receive industry-wide recognition, securing prestigious accolades that reinforce its market leadership. The company has been named Best in KLAS for Medical Transcription Services for the seventh consecutive year and was recognized as the Top-Ranked Provider for Clinical Documentation & Medical Coding by Black Book Market Surveys. Additionally, its acquisition of AQuity Solutions earned it the Healthcare/Life Sciences Deal of the Year (>100MM) at the M&A Advisor International Awards.

    Scaling for the Future: The Road Ahead
    With a robust global presence across North America, Canada, Australia, and India, IKS Health is poised for continued growth and market dominance. The company is doubling down on investments in:

    • Expanding AI-powered automation for clinical and revenue cycle management.
    • Deepening its presence in value-based care models.
    • Strengthening partnerships with top healthcare enterprises and physician groups worldwide.

    IKS Health’s stellar Q3 FY25 results reaffirm its ability to scale with precision, using AI and automation as key differentiators. With a focus on transforming healthcare enterprises through technology-driven care enablement, IKS Health is redefining the future of digital health innovation.

    About IKS Health
    IKS Health is a leading provider of AI-powered automation solutions for healthcare enterprises, specializing in clinical documentation, revenue cycle management, and patient engagement. Founded in 2006, IKS Health supports some of the largest physician groups, hospitals, and healthcare systems globally, helping them scale with AI-driven operational efficiencies.
    The company was listed on the National Stock Exchange (NSE: IKS) and Bombay Stock Exchange (BSE: 544309) on December 19, 2024. With a global workforce of over 7,000 employees, IKS Health remains committed to advancing AI-powered healthcare transformation worldwide.
    Led by Prittle Prattle News, this coverage showcases the latest in AI-driven healthcare innovation. Stay updated by following Smruti Bhalerao on LinkedIn. For more insights, visit Prittle Prattle News or follow us on Instagram and YouTube.

  • India’s Silent Education Crisis: How Menstrual Stigma is Forcing 60% of Teenage Girls Out of School

    Why Policy Gaps, Social Taboos, and Neglect of Menstrual Hygiene Are Hurting India’s Future

    Menstrual stigma continues to keep millions of adolescent girls out of classrooms in India. According to UNICEF, more than 71% of girls in India do not know about menstruation before their first period. The consequences are devastating, with 60% of teenage girls dropping out of school due to the lack of access to clean toilets, sanitary products, and menstrual hygiene education.
    The World Bank estimates that increasing female workforce participation could boost India’s GDP by 27%, but menstrual health remains one of the biggest obstacles in achieving this goal. The problem is not just rural—period stigma exists even in urban centers, where sanitary products are still hidden in black plastic bags and menstruation is spoken about in hushed tones.
    Despite policies like Beti Bachao Beti Padhao, India’s menstrual hygiene infrastructure remains largely inadequate, leaving adolescent girls vulnerable to missed education, economic hardship, and health risks.

    Why Are Girls Still Dropping Out of School?
    The National Family Health Survey (NFHS-5) reports that only 48% of Indian schools have separate toilets for girls. In rural schools, many do not have running water, soap, or disposal facilities for menstrual products. Without these basic necessities, girls are forced to stay home for several days each month. Over time, these absences lead to permanent dropouts, limiting future opportunities.
    The problem extends beyond school infrastructure. UNESCO estimates that 23 million Indian girls drop out annually due to period poverty, a term used to describe inaccessibility to affordable menstrual products. Many are forced to rely on cloth, ash, sand, or other unsafe alternatives, increasing their risk of urinary tract infections (UTIs) and reproductive health issues.
    Social stigma remains a significant barrier. Pee Safe founder Vikas Bagaria highlighted in the What India Needs! Podcast that menstrual myths still control how women experience their periods.
    In urban areas, menstrual products are still wrapped in newspaper or hidden in black plastic bags. This stigma is forcing women into silence instead of creating open conversations about hygiene and access, Bagaria said.

    The Menstrual Waste Crisis: A Growing Environmental Threat
    With more than 355 million menstruating women in India, menstrual waste is a major environmental challenge. The United Nations Environment Programme (UNEP) estimates that over 12.3 billion sanitary pads are discarded annually in India, leading to 113,000 tons of non-biodegradable waste. Most of these take 500-800 years to decompose.
    Paul pointed out that this crisis requires urgent action.The amount of menstrual waste being generated in India is enormous. There needs to be a policy-level intervention to promote sustainable alternatives, such as biodegradable pads and menstrual cups.
    Bagaria added that sustainable period products aren’t as expensive as people assume. “A menstrual cup costs ₹400-600 but lasts for five years. A biodegradable sanitary pad costs about ₹3,000 annually, which is cheaper than many daily-use products,” he said.

    How Other Countries Are Tackling Menstrual Health
    India is not alone in facing menstrual hygiene challenges. However, other countries have taken bolder steps to address the issue:

    • Scotland became the first country in the world to provide free period products to all women through government funding.
    • Kenya removed taxes on menstrual products, making them more affordable for low-income communities.
    • Bangladesh launched nationwide menstrual health education campaigns to reduce stigma and improve awareness.

    These policies have directly reduced school dropouts and improved menstrual hygiene awareness. India has yet to implement large-scale government programs to make menstrual products widely available for free.

    Why Men Must Join the Conversation
    Menstrual health is often treated as a “women’s issue”, but changing male perspectives is critical in tackling stigma. Pee Safe’s “Men Buy Pads” campaign encourages fathers, brothers, and husbands to take an active role in purchasing menstrual products.
    Paul noted that educating boys in schools about menstrual health could eliminate stigma over time. If boys grow up knowing that periods are normal, they will not reinforce harmful myths when they become adults,” she said.
    Bagaria emphasized that male hygiene education is also lacking in India. Men don’t face the same taboos as women, but male hygiene habits are rarely discussed, which leads to serious health risks. Pee Safe has expanded its product line to include men’s intimate washes, designed to maintain pH balance and prevent infections.
    What’s Next for Menstrual Hygiene in India?
    The Indian menstrual hygiene market is projected to grow to $2.5 billion within the next decade, with penetration rates expected to reach 70-75%. However, Bagaria believes awareness is still the biggest hurdle.
    “Innovation in menstrual hygiene is growing, but if people don’t accept these products, the problem remains,” he said.
    Beyond innovation, policy-level changes are needed. India must:
    • Implement free sanitary pad distribution programs in government schools, similar to Scotland’s model.
    • Remove taxes on menstrual hygiene products, making them more affordable for low-income women.
    • Expand menstrual health education to all schools, targeting both boys and girls.
    • Improve sanitation infrastructure in schools by ensuring all institutions have separate toilets, clean water, and disposal facilities.
    Watch the Full Podcast Discussion
    🎧 Listen on Spotify: What India Needs! Podcast – Pee Safe
    📺 Watch on YouTube: Full Episode
    At Prittle Prattle News, we bring insightful journalism that sparks change. Led by Smruti Bhalerao, we deliver high-impact stories that shape policy, drive awareness, and inspire action. Follow us on LinkedIn, Instagram, and YouTube for more exclusive insights.

  • Kokilaben Hospital Becomes India’s First European-Certified Endometriosis Center, Revolutionizing Women’s Healthcare

    Bridging India’s Healthcare Gap with Global-Standard Endometriosis Treatment

    Endometriosis, a painful and often misdiagnosed condition, affects 10-15% of Indian women, yet many go years without proper diagnosis or treatment. Women struggling with severe pelvic pain, menstrual disorders, and unexplained infertility often face fragmented care, outdated treatments, and limited access to minimally invasive surgeries. Despite affecting 247 million women globally, endometriosis remains one of the least understood conditions in India’s healthcare system.
    For the first time in India, a dedicated multidisciplinary center is changing this reality. Kokilaben Dhirubhai Ambani Hospital (KDAH) has become the first and only hospital in India to receive the EuroEndoCert certification from the European Endometriosis League. This prestigious accreditation, previously awarded only to leading hospitals in Europe and the U.S., validates KDAH’s world-class treatment model, setting a new benchmark for women’s healthcare in India.
    This recognition is not just an award: it is a transformational shift in how endometriosis is treated in India. The certification ensures that KDAH follows the same advanced diagnostic and treatment protocols as those used in Germany, France, and the United Kingdom. Patients now have access to gold-standard treatments, including robotic-assisted laparoscopic surgery, specialized pain management, and fertility-preserving interventions.

    Why India Needed a Global-Standard Endometriosis Center
    Unlike in Germany and Australia, where endometriosis is widely recognized and treated early, India has no standardized treatment guidelines, leading to delayed diagnosis and poor patient outcomes. Studies suggest that Indian women often wait over a decade before being correctly diagnosed, compared to the global average of 7-10 years.
    A report by the World Health Organization (WHO) confirms that 50% of women with endometriosis experience infertility, yet India lacks a coordinated approach to managing both conditions together. Unlike hospitals in the U.S. and the U.K., which integrate gynecology, pain management, and reproductive medicine, most Indian hospitals focus only on surgery, leaving patients without long-term disease management solutions.
    KDAH’s certified Endometriosis Clinic changes this model entirely by offering a comprehensive, patient-first approach. It brings together gynecologists, radiologists, pain specialists, colorectal surgeons, and fertility experts: ensuring that women receive holistic, research-backed treatment rather than temporary symptom relief.

    A Step Forward for Indian Women’s Health & Infertility Treatment
    The impact of endometriosis on fertility remains one of its most devastating consequences. Research shows that 40-50% of women diagnosed with the condition struggle to conceive, as scar tissue, inflammation, and hormonal imbalances affect the ovaries and fallopian tubes. Many women only discover they have endometriosis when they face difficulties getting pregnant.
    Kokilaben Hospital is tackling this issue head-on by integrating advanced fertility treatments into its endometriosis care model. This includes:

    • Specialized laparoscopic and robotic-assisted surgeries designed to remove lesions without damaging ovarian reserves.
    • Personalized hormonal therapy protocols that help preserve egg quality while managing symptoms.
    • Dedicated fertility counseling and ART (Assisted Reproductive Technologies), including In Vitro Fertilization (IVF) and Intrauterine Insemination (IUI) for endometriosis patients.

    By adopting these evidence-based protocols, KDAH ensures that women suffering from endometriosis receive both effective pain management and fertility support, helping them build families without unnecessary delays.

    How KDAH’s EuroEndoCert Recognition Transforms Women’s Healthcare in India
    Before this certification, endometriosis treatment in India was inconsistent, with most hospitals relying on outdated techniques. The introduction of EuroEndoCert standards now places KDAH on par with the world’s top endometriosis treatment centers in France and Sweden.
    The certification confirms that KDAH is following:

    • European-standard diagnostic guidelines, reducing misdiagnosis rates.
    • Minimally invasive robotic and laparoscopic surgeries, leading to faster recovery and reduced recurrence rates.
    • Pain management strategies that go beyond surgery, incorporating nerve-block therapies and neuromodulation techniques.
    • Comprehensive patient education and awareness initiatives, ensuring that women seek treatment earlier rather than waiting years for a diagnosis.

    A Landmark Moment for Women’s Healthcare Policy in India
    Beyond transforming patient care, this certification has broader policy implications for India’s healthcare system. Currently, India spends less than $5 million annually on endometriosis research, compared to $120 million in the U.S. and $78 million in Australia.
    KDAH’s leadership in this field could drive national-level changes, including:

    • Implementation of endometriosis screening programs in hospitals across India.
    • Inclusion of endometriosis in national health policies, similar to the UK’s Endometriosis Action Plan.
    • More government funding for research, leading to better treatment accessibility for all Indian women.
    A Message from the Experts
    Dr. Anshumala Shukla-Kulkarni, Head of Minimally Invasive Gynecology & Robotic Surgery at KDAH, highlights the urgency of this advancement:
    – This certification validates our mission to transform endometriosis care in India. No woman should suffer in silence or wait years for an accurate diagnosis. Our multidisciplinary approach ensures that patients receive cutting-edge treatment, pain management, and fertility support: all in one place.- 
    Dr. Santosh Shetty, CEO & Executive Director of KDAH, emphasizes the larger impact:
    – This is a historic moment, not just for our hospital but for India’s entire healthcare system. We hope this recognition encourages other hospitals to adopt a more holistic, research-driven approach to women’s health.- 
    Conclusion: A Game-Changer for Indian Women’s Health
    KDAH’s EuroEndoCert certification marks a turning point for endometriosis treatment in India. By aligning with global best practices, the hospital is setting a new standard for patient care, bridging the gap between Indian healthcare and world-class medical advancements.
    For the millions of Indian women suffering in silence, this is more than just a certification: it’s a lifeline to better health, improved fertility outcomes, and a future free from chronic pain.
    At Prittle Prattle News, featuring you virtuously, we celebrate commitment and innovation. Led by Editor-in-Chief Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.